Cargando…

Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study

BACKGROUND: Colon cancer (CC) is the third most commonly diagnosed malignant tumor and remains the second leading cause of cancer-related deaths worldwide. However, the risk assessment of poor prognosis of CC is limited in previous studies. This study aimed to develop a predictive nomogram for the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Lai, Xiaorong, Yang, Dongyang, Ma, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660070/
https://www.ncbi.nlm.nih.gov/pubmed/36388692
http://dx.doi.org/10.21037/jgo-22-878
_version_ 1784830344072003584
author Li, Ying
Lai, Xiaorong
Yang, Dongyang
Ma, Dong
author_facet Li, Ying
Lai, Xiaorong
Yang, Dongyang
Ma, Dong
author_sort Li, Ying
collection PubMed
description BACKGROUND: Colon cancer (CC) is the third most commonly diagnosed malignant tumor and remains the second leading cause of cancer-related deaths worldwide. However, the risk assessment of poor prognosis of CC is limited in previous studies. This study aimed to develop a predictive nomogram for the survival of CC patients. METHODS: In this retrospective cohort study, 113,239 CC patients from the Surveillance, Epidemiology, and End Results (SEER) database were randomly divided into training (n=56,619) and testing (n=56,620) sets with a ratio of 1:1. Demographic, clinical data and survival status of patients were extracted. The outcomes were 3- and 5-year survival of CC. Univariate and multivariate Cox regression analyses were used to screen the predictors to develop the predictive nomogram. Internal validation and stratified analyses were further assessed the nomogram. The C-index and area under the curve (AUC) were calculated to estimate the model’s predictive capacity, and calibration curves were adopted to estimate the model fit. RESULTS: Totally 38,522 (34.02%) patients died during the 5-year follow-up. The nomogram incorporated variables associated with the prognosis of CC patients, including age, gender, marital status, insurance status, tumor grade, stage (T/N/M), surgery, and number of nodes examined, with a C-index of 0.775 in the training set and 0.774 in the testing set. The AUCs of the nomogram for the 3- and 5-year survival prediction in the training set were 0.817 and 0.808, with the sensitivity of 0.688 and 0.716, and the specificity of 0.785 and 0.740, respectively. Similar results were found in the testing set. The C-index of the predictive nomogram for male, female, White, Black, and other races was 0.769, 0.779, 0.773, 0.770, and 0.770, respectively. The calibration curves for the nomogram in the above five cohorts showed a good agreement between actual and predicted values. CONCLUSIONS: The nomogram may exhibit a certain predictive performance based on the SEER database, which may provide individual survival predictions for CC patients.
format Online
Article
Text
id pubmed-9660070
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-96600702022-11-15 Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study Li, Ying Lai, Xiaorong Yang, Dongyang Ma, Dong J Gastrointest Oncol Original Article BACKGROUND: Colon cancer (CC) is the third most commonly diagnosed malignant tumor and remains the second leading cause of cancer-related deaths worldwide. However, the risk assessment of poor prognosis of CC is limited in previous studies. This study aimed to develop a predictive nomogram for the survival of CC patients. METHODS: In this retrospective cohort study, 113,239 CC patients from the Surveillance, Epidemiology, and End Results (SEER) database were randomly divided into training (n=56,619) and testing (n=56,620) sets with a ratio of 1:1. Demographic, clinical data and survival status of patients were extracted. The outcomes were 3- and 5-year survival of CC. Univariate and multivariate Cox regression analyses were used to screen the predictors to develop the predictive nomogram. Internal validation and stratified analyses were further assessed the nomogram. The C-index and area under the curve (AUC) were calculated to estimate the model’s predictive capacity, and calibration curves were adopted to estimate the model fit. RESULTS: Totally 38,522 (34.02%) patients died during the 5-year follow-up. The nomogram incorporated variables associated with the prognosis of CC patients, including age, gender, marital status, insurance status, tumor grade, stage (T/N/M), surgery, and number of nodes examined, with a C-index of 0.775 in the training set and 0.774 in the testing set. The AUCs of the nomogram for the 3- and 5-year survival prediction in the training set were 0.817 and 0.808, with the sensitivity of 0.688 and 0.716, and the specificity of 0.785 and 0.740, respectively. Similar results were found in the testing set. The C-index of the predictive nomogram for male, female, White, Black, and other races was 0.769, 0.779, 0.773, 0.770, and 0.770, respectively. The calibration curves for the nomogram in the above five cohorts showed a good agreement between actual and predicted values. CONCLUSIONS: The nomogram may exhibit a certain predictive performance based on the SEER database, which may provide individual survival predictions for CC patients. AME Publishing Company 2022-10 /pmc/articles/PMC9660070/ /pubmed/36388692 http://dx.doi.org/10.21037/jgo-22-878 Text en 2022 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Li, Ying
Lai, Xiaorong
Yang, Dongyang
Ma, Dong
Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
title Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
title_full Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
title_fullStr Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
title_full_unstemmed Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
title_short Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
title_sort development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660070/
https://www.ncbi.nlm.nih.gov/pubmed/36388692
http://dx.doi.org/10.21037/jgo-22-878
work_keys_str_mv AT liying developmentandvalidationofasurvivalpredictionmodelfor113239patientswithcoloncanceraretrospectivecohortstudy
AT laixiaorong developmentandvalidationofasurvivalpredictionmodelfor113239patientswithcoloncanceraretrospectivecohortstudy
AT yangdongyang developmentandvalidationofasurvivalpredictionmodelfor113239patientswithcoloncanceraretrospectivecohortstudy
AT madong developmentandvalidationofasurvivalpredictionmodelfor113239patientswithcoloncanceraretrospectivecohortstudy